
BridgeBio Pharma Hits New 52-Week High of $69.48, Up 139.38%
2025-10-30 18:51:02BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. The company, with a market capitalization of USD 10,715 million, showcases strong operational efficiency despite being currently loss-making, highlighted by its notable return on equity.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






